<DOC>
	<DOCNO>NCT02907463</DOCNO>
	<brief_summary>The purpose active , observational , open-label , non-randomized , post-market surveillance study confirm EDWARDS INTUITY Elite reduce cross clamp time ( XCT ) MIS set compare publish data conventional valve within MIS set . The published dataset use control group . Then describe short term ( 30 day ) long term ( 6 month ) clinical safety , assess compare hemodynamic data EDWARDS INTUITY Elite conventional valve discharge 6 month post AVR , ass Quality Life baseline , 6 month post AVR ass NYHA functional class baseline , discharge , 1 month 6 month post AVR ass Fitness hospital discharge .</brief_summary>
	<brief_title>EDWARDS INTUITY Elite Valve System</brief_title>
	<detailed_description>Aortic valve replacement mechanical biological heart valves treatment choice aortic valve stenosis . Over past several year , life expectancy increase industrial nation , accompany rise rate elderly patient multiple illness . Aortic stenosis remain common cause adult valvular heart disease , prevalence increase age . Average survival patient treat conservatively historically report 2—5 year onset symptom . More recent study confirm dismal prognosis severe aortic stenosis . Advanced age , reduce left-ventricular ejection fraction , congestive heart failure renal insufficiency appear independent predictor reduce survival . Asymptomatic patient severe aortic stenosis also share poor prognosis high event rate risk rapid functional deterioration . Early surgery offer therapeutic option improve clinical outcome via decrease cardiac mortality improve symptom . Bioprostheses offer several advantage mechanical bioprostheses , important freedom anticoagulation low rate thromboembolic accident . In response clinical need support advance minimally invasive surgical approach conventional AVR , Edwards Lifesciences develop EDWARDS INTUITY Elite Valve System achieve clinical benefit reduce cardiopulmonary bypass cross clamp time , facilitate less invasive approach aortic valve replacement . The system include EDWARDS INTUITY Elite Valve System , Model 8300AB EDWARDS INTUITY Elite Delivery System , Model 8300DB ; valve base prior heart valve design long history safety effectiveness incorporate additional feature design improve patient outcomes safety . With 3 guide suture secure balloon expandable frame , EDWARDS INTUITY Elite Valve system well suit small incision tight access , emphasis procedural efficiency within exist operate suite surgeon .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>1 . Subject 18 year old 2 . Subject symptomatic aortic stenosis ( AS ) mixed aortic stenosis aortic insufficiency ( AS/AI ) disease isolate surgical aortic valve replacement without concomitant procedure indicate accord International guideline . 3 . Surgery start intend complete via minimal invasive surgical approach . MIS define nonfull sternotomy approach partial hemisternotomy , right anterior thoracotomy . 4 . Surgery intend complete EDWARDS INTUITY Elite Heart Valve . 5 . Subject sign dated investigation inform consent form prior studyspecific procedure perform . 6 . Subject geographically stable agrees attend followup assessment specify protocol inform consent . 1 . Subject diagnosed pure aortic insufficiency . 2 . Subject require multiple valve replacement/repair 3 . Subject Type 0 congenital true bicuspid aortic valve ( i.e . absence raphe commissure position 180 degree apart ) unicuspid aortic valve . 4 . Subject severe ventricular dysfunction define LVEF &lt; 25 % . 5 . Subject history active endocarditis and/or myocarditis ≤ 3 month intend treatment/scheduled surgery . 6 . Subject acute MI ≤ 3 month intend treatment . 7 . Subject stroke transient ischemic attack within six month prior schedule aortic valve replacement surgery . 8 . Subject oxygen ventilator dependent . 9 . Subject life expectancy &lt; 12 month . 10 . Female subject pregnant lactating . 11 . Subject document leukopenia ( WBC &lt; 3.5x 103/μL ) , anemia ( Hb &lt; 10.0 gm/dL &lt; 6.2 mmol/L ) , thrombocytopenia ( platelet count &lt; 100x 103/mL ) , history bleed diathesis coagulopathy . 12 . Subject renal insufficiency determine Serum creatinine ≥ 200 μmol/L ( 2.27 mg/dL ) screening endstage renal disease require chronic dialysis . 13 . Subject currently participate investigational drug device trial followup yet complete . 14 . Minimally Invasive access heart possible due anatomical constraint preexist condition . 15 . Aneurysm aortic root and/or ascend aorta Intraoperative exclusion criterion : 1 . Subject Type 0 congenital true bicuspid aortic valve ( i.e . absence raphe commissure position 180 degree apart ) unicuspid aortic valve . ( A noncongenital bicuspid valve without distorted annulus would cause exclusion . ) 2 . Subject calcium anterior mitral leaflet remove . 3 . Subject extensive calcification aortic root . 4 . Annular deformation may may cause extensive decalcification aortic annulus . 5 . The position coronary ostia relative EDWARDS INTUITY Elite Aortic Valve could result obstruction blood flow . 6 . Minimally Invasive access heart possible due anatomical constraint condition ( include patient switch full sternotomy approach ) . 7 . The device available correct size subject .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Aortic Valve Replacement</keyword>
	<keyword>Aortic Stenosis</keyword>
	<keyword>EDWARDS INTUITY Elite</keyword>
	<keyword>Rapid deployment valve</keyword>
</DOC>